1-3 of 3
Le Min
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders

Chanjuan Ma, F. Stephen Hodi, Anita Giobbie-Hurder, Xiaocheng Wang, Jing Zhou, Amy Zhang, Ying Zhou, Fei Mao, Trevor E. Angell, Chelsea P. Andrews, Jiani Hu, Romualdo Barroso-Sousa, Ursula B. Kaiser, Sara M. Tolaney, Le Min
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (7): 1214–1220.
https://doi.org/10.1158/2326-6066.CIR-18-0613
Published: 01 July 2019
View article titled, The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders
Open the PDF for The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders in another window
Includes: Supplementary data
Journal Articles

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Hyunju Lee, F. Stephen Hodi, Anita Giobbie-Hurder, Patrick A. Ott, Elizabeth I. Buchbinder, Rizwan Haq, Sara Tolaney, Romualdo Barroso-Sousa, Kevin Zhang, Hilary Donahue, Meredith Davis, Maria E. Gargano, Kristina M. Kelley, Rona S. Carroll, Ursula B. Kaiser, Le Min
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (12): 1133–1140.
https://doi.org/10.1158/2326-6066.CIR-17-0208
Published: 30 November 2017
View article titled, Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
Open the PDF for Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy in another window
Journal Articles

Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis

Le Min, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (1): 15–18.
https://doi.org/10.1158/2326-6066.CIR-13-0146
Published: 02 January 2014
View article titled, Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis
Open the PDF for Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and Rhabdomyolysis in another window